Literature DB >> 12574386

Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease.

Iñigo Goya1, Ricardo Villares, Angel Zaballos, Julio Gutiérrez, Leonor Kremer, José-Angel Gonzalo, Rosa Varona, Laura Carramolino, Alfredo Serrano, Pilar Pallarés, Luis Miguel Criado, Roland Kolbeck, Miguel Torres, Anthony J Coyle, José-Carlos Gutiérrez-Ramos, Carlos Martínez-A, Gabriel Márquez.   

Abstract

Interaction of chemokines with their specific receptors results in tight control of leukocyte migration and positioning. CCR8 is a chemokine receptor expressed mainly in CD4(+) single-positive thymocytes and Th2 cells. We generated CCR8-deficient mice (CCR8(-/-)) to study the in vivo role of this receptor, and describe in this study the CCR8(-/-) mouse response in OVA-induced allergic airway disease using several models, including an adoptive transfer model and receptor-blocking experiments. All CCR8(-/-) mice developed a pathological response similar to that of wild-type animals with respect to bronchoalveolar lavage cell composition, peripheral blood and bone marrow eosinophilia, lung infiltrates, and Th2 cytokine levels in lung and serum. The results contrast with a recent report using one of the OVA-induced asthma models studied here. Similar immune responses were also observed in CCR8(-/-) and wild-type animals in a different model of ragweed allergen-induced peritoneal eosinophilic inflammation, with an equivalent number of eosinophils and analogous increased levels of Th2 cytokines in peritoneum and peripheral blood. Our results show that allergic diseases course without critical CCR8 participation, and suggest that further work is needed to unravel the in vivo role of CCR8 in Th2-mediated pathologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574386     DOI: 10.4049/jimmunol.170.4.2138

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung.

Authors:  Cyrille Mionnet; Vanessa Buatois; Akira Kanda; Valerie Milcent; Sebastien Fleury; David Lair; Marie Langelot; Yannick Lacoeuille; Edith Hessel; Robert Coffman; Antoine Magnan; David Dombrowicz; Nicolas Glaichenhaus; Valerie Julia
Journal:  Nat Med       Date:  2010-10-31       Impact factor: 53.440

2.  iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

Authors:  Everett H Meyer; Marc-André Wurbel; Tracy L Staton; Muriel Pichavant; Matthew J Kan; Paul B Savage; Rosemarie H DeKruyff; Eugene C Butcher; James J Campbell; Dale T Umetsu
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 3.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 4.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

5.  The Chemokine Receptor CCR8 Promotes the Migration of Dendritic Cells into the Lymph Node Parenchyma to Initiate the Allergic Immune Response.

Authors:  Caroline L Sokol; Ryan B Camire; Michael C Jones; Andrew D Luster
Journal:  Immunity       Date:  2018-08-28       Impact factor: 31.745

6.  A new approach for analyzing cellular infiltration during allergic airway inflammation.

Authors:  Peter R Hoffmann; Alexandra Gurary; Fukun W Hoffmann; Claude Jourdan-Le Saux; Kelsa Teeters; Ann C Hashimoto; Elizabeth K Tam; Marla J Berry
Journal:  J Immunol Methods       Date:  2007-08-27       Impact factor: 2.303

7.  Expression of CCR8 is increased in asthma.

Authors:  K Mutalithas; C Guillen; C Raport; R Kolbeck; D Soler; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-04-28       Impact factor: 5.018

8.  CCR4 blockade does not inhibit allergic airways inflammation.

Authors:  Dolores M Conroy; Louise A Jopling; Clare M Lloyd; Martin R Hodge; David P Andrew; Timothy J Williams; James E Pease; Ian Sabroe
Journal:  J Leukoc Biol       Date:  2003-07-15       Impact factor: 4.962

9.  CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation.

Authors:  Benjamin D Medoff; Edward Seung; Sandra Hong; Seddon Y Thomas; Barry P Sandall; Jeremy S Duffield; Douglas A Kuperman; David J Erle; Andrew D Luster
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donors.

Authors:  D Ahern; C M Lloyd; D S Robinson
Journal:  Allergy       Date:  2009-02-07       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.